CyFlow CD84 Low Endotoxin
品番 | BZ199994 | ||
---|---|---|---|
抗体名 | Anti-Hu CD84 LOW END,CD84.1.21 | ||
包装単位 | 0.1 mg | ||
濃度 | 1 mg/ml | ||
容量 | 0.1 ml | ||
関連製品 (アイソタイプコントロール) |
Mouse IgG2a Low Endotoxin (AN242943) |
||
反応性|交差吸着 | Human | レーザー | |
抗原 | CD84, SLAMF5 | 最大蛍光波長 | - |
クローン | CD84.1.21 | 最大励起波長 | - |
ホスト | Mouse | 標識/Format | Low Endotoxin |
アイソタイプ | IgG2a | 研究分野 | Immunophenotyping |
クローナリティ | monoclonal | 用途 | Flow cytometry |
Anti-Hu CD84 LOW END,CD84.1.21
特異性
The mouse monoclonal antibody CD84.1.21 recognizes CD84 antigen, a single chain cell surface glycoprotein of 64-82 kDa, predominantly expressed B cells, monocytes, platelets and some T cells.
抗原情報
CD84 is a highly glycosylated homophilic receptor of SLAM family. It is expressed on platelets and various types of leukocytes, especially following their activation. Ligation of CD84 leads to its phosphorylation on tyrosine residues within the cytoplasmic tail. These docking sites are recognized by downstream signaling molecules, such as phosphatase SHP-2 and adaptor protein SAP/SH2D1A. The function of CD84 has not been fully elucidated yet. Although predominantly activating receptor, its modulating activity was also demonstrated.
利用方法
保存方法
Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
安定性情報
Do not use after expiration date stamped on vial label.
レファレンス
• Martin M, Romero X, de la Fuente MA, Tovar V, Zapater N, Esplugues E, Pizcueta P, Bosch J, Engel P: CD84 functions as a homophilic adhesion molecule and enhances IFN‑gamma secretion: adhesion is mediated by Ig‑like domain 1. J·Immunol. 2001·Oct·1; 167(7):3668‑76. <·PMID:·11564780·>
• Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, Gullo C, Howie D, Rietdijk S, Thompson A, Coyle AJ, Denny C, Yaffe MB, Engel P, Eck MJ, Terhorst C: Structural basis for the interaction of the free SH2 domain EAT‑2 with SLAM receptors in hematopoietic cells. EMBO·J. 2001·Nov·1; 20(21):5840‑52. <·PMID:·11689425·>
• Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C: Characterization of SH2D1A missense mutations identified in X‑linked lymphoproliferative disease patients. J·Biol·Chem. 2001·Sep·28; 276(39):36809‑16. <·PMID:·11477068·>
• Romero X, Zapater N, Calvo M, Kalko SG, de la Fuente MA, Tovar V, Ockeloen C, Pizcueta P, Engel P: CD229 (Ly{09} lymphocyte cell surface receptor interacts homophilically through its N‑terminal domain and relocalizes to the immunological synapse. J·Immunol. 2005·Jun·1; 174(11):7033‑42. <·PMID:·15905546·>
• Sayós J, Martín M, Chen A, Simarro M, Howie D, Morra M, Engel P, Terhorst C: Cell surface receptors Ly‑9 and CD84 recruit the X‑linked lymphoproliferative disease gene product SAP. Blood. 2001·Jun·15; 97(12):3867‑74. <·PMID:·11389028·>
Available Safety Data Sheets
CyFlow™ monoclonal antibodies SDS CA EN